Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Eleanor Stride (Department of Engineering Science and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science) has taken an unconventional path to becoming one of Britain’s leading scientists. In a new Oxford Science Blog, she tells Sarah Whitebloom how she moved from dance to design and onto biomedical science, but being a 'woman in science' is not one of the identities she seeks.

Professor Eleanor Stride © New York Academy of Sciences/ Blavatnik Awards for Young Scientists

When is a woman in science not a ‘woman in science’? When she is a woman in science.

At the risk of generalisation, women in science are hard-working, dedicated, cutting edge…scientists.  Call them ‘women in science’ at your peril.  Women in science will tell you quite firmly that they do not want to be treated differently or feel they do not deserve their place. Any hint of tokenism will be greeted with a frosty response. 

And Professor Eleanor Stride is an uber scientist, which is nothing to do with mini-cabs but everything to do with dedication, hard-work and world-changing ideas.  It is hard to imagine that she has ever felt she is making up the numbers.

‘You’d be surprised,’ she says. Sometimes, it is felt that there has to be a woman involved and no one wants to be that woman.  Professor Stride maintains there is, of course, a need for more women in science and is infuriated at the idea that girls are still told that Maths and science is not for them. She is, quite literally, furious at the ‘Mummy wasn’t any good at Maths’, sort of parental advice. And, she says, the counter-balance needs to start early, at Primary School, when girls start to drift away from the sciences and Maths.

Read the full blog on the University of Oxford website

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.